search
Back to results

Illness Management and Parental Adjustment to Cancer Treatment (IMPACT)

Primary Purpose

Solid Tumor, Leukemia, Lymphoma

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
IMPACT
ESO
Sponsored by
Children's Hospital Medical Center, Cincinnati
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Solid Tumor focused on measuring Intervention, Illness Uncertainty, Childhood Cancer, Solid Tumor, Leukemia, Lymphoma, Brain Tumor, Randomized clinical trial, Parental uncertainty management intervention, Parent, Oncology, Pediatric

Eligibility Criteria

0 Years - 18 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • The child has been diagnosed with leukemia or lymphoma, malignant solid tumor, or malignant brain tumor
  • The child is being treated for cancer and returning to the medical center (CCHMC or OUHSC).
  • The child is 18 years of age or younger
  • Recruitment occurs within 2-12 weeks post diagnosis
  • The parent is responsible for care and is willing to give consent and participate
  • The child is willing to give assent or consent and participate (only for children 8 years old and older)
  • The parent gives patient permission to participate.
  • Parent is fluent in English

Exclusion Criteria:

  • The child is experiencing an imminent medical crisis necessitating significant medical intervention
  • The child with cancer is determined to be in the terminal phase of illness and/or is receiving end of life care
  • The diagnosis is determined to be a relapse or a second malignancy
  • The parent is currently being treated for a serious psychiatric disorder, or, evidences mental retardation
  • The parent is younger than 18 years of age
  • The parent is not English speaking
  • The parent is unwilling to give written permission for child participation
  • If the patient's treatment visit schedule is too infrequent to meet the study visit timeline requirements

Sites / Locations

  • Cincinnati Children's Hospital Medical Center
  • Dayton Children's Hospital
  • University of Oklahoma Health Sciences Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

Parent Uncertainty Intervention

Education/Support Only

Arm Description

A pediatric cancer-specific, clinic based, six-module interdisciplinary uncertainty intervention. Modules one through three target uncertainty prevention. Modules four through six target uncertainty responses for situations in which uncertainty cannot be prevented or avoided.

Sessions in this condition aim to provide education on cancer etiology, medical treatments, side effects, potential short- and long-term effects of treatment and resources that are often helpful to parents of children with cancer. Information presented will be based upon, "Young People with Cancer: A Handbook for Parents", a parent resource developed by the National Cancer Institute. Parents will also be provided with relevant educational brochures from COG. Each session will also include a structured set of questions that will facilitate discussion. All ESO interventionists will be trained in non-directive approaches including reflective listening. Content provided in the ESO sessions will offer valuable information to parents without providing the specific skills of the IMPACT.

Outcomes

Primary Outcome Measures

Psychosocial Functioning as assessed by the global severity index (GSI) of the symptom checklist 90.
indicator of global psychological symptoms
Psychosocial Functioning as assessed by the global severity index of the symptom checklist 90.
indicator of global psychological symptoms
Psychosocial Functioning as assessed by the global severity index of the symptom checklist 90.
indicator of global psychological symptoms
Psychosocial Functioning as assessed by the global severity index of the symptom checklist 90.
indicator of global psychological symptoms

Secondary Outcome Measures

Post-Traumatic Stress Symptoms as assessed by the Impact of Events Scale-Revised (IES-R)
Measure of caregiver post-traumatic stress symptoms
Post-Traumatic Stress Symptoms as assessed by the Impact of Events Scale-Revised (IES-R)
Measure of caregiver post-traumatic stress symptoms
Post-Traumatic Stress Symptoms as assessed by the Impact of Events Scale-Revised (IES-R)
Measure of caregiver post-traumatic stress symptoms
Post-Traumatic Stress Symptoms as assessed by the Impact of Events Scale-Revised (IES-R)
Measure of caregiver post-traumatic stress symptoms

Full Information

First Posted
June 17, 2015
Last Updated
April 5, 2022
Sponsor
Children's Hospital Medical Center, Cincinnati
Collaborators
University of Oklahoma, Oklahoma State University, Dayton Children's Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT02505165
Brief Title
Illness Management and Parental Adjustment to Cancer Treatment
Acronym
IMPACT
Official Title
A Clinic-Based Interdisciplinary Intervention for Parents of Children With Cancer
Study Type
Interventional

2. Study Status

Record Verification Date
April 2022
Overall Recruitment Status
Completed
Study Start Date
November 19, 2015 (Actual)
Primary Completion Date
April 22, 2021 (Actual)
Study Completion Date
February 1, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Children's Hospital Medical Center, Cincinnati
Collaborators
University of Oklahoma, Oklahoma State University, Dayton Children's Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to test the efficacy of a clinic-based intervention designed to reduce illness uncertainty for parents of children who have been recently diagnosed with cancer.
Detailed Description
The proposed trial will test the efficacy of the parent-focused clinic-based Parent Uncertainty Management Intervention (PUMI) to improve the outcomes of children newly diagnosed with cancer and their parents. Participants will be randomly assigned to receive equivalent doses of either the PUMI or an Education/Support (ESO) group. Theoretically driven by Mishel's model of illness uncertainty, the PUMI will teach parents about uncertainty prevention and management through the use of medically-specific communication, information management, and problem-solving skills via in-clinic sessions and an online portal. Parents and children will complete measures online at baseline, 1-week, and 3-, 6-, and 12-month follow-ups.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Solid Tumor, Leukemia, Lymphoma, Brain Tumor
Keywords
Intervention, Illness Uncertainty, Childhood Cancer, Solid Tumor, Leukemia, Lymphoma, Brain Tumor, Randomized clinical trial, Parental uncertainty management intervention, Parent, Oncology, Pediatric

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
279 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Parent Uncertainty Intervention
Arm Type
Experimental
Arm Description
A pediatric cancer-specific, clinic based, six-module interdisciplinary uncertainty intervention. Modules one through three target uncertainty prevention. Modules four through six target uncertainty responses for situations in which uncertainty cannot be prevented or avoided.
Arm Title
Education/Support Only
Arm Type
Other
Arm Description
Sessions in this condition aim to provide education on cancer etiology, medical treatments, side effects, potential short- and long-term effects of treatment and resources that are often helpful to parents of children with cancer. Information presented will be based upon, "Young People with Cancer: A Handbook for Parents", a parent resource developed by the National Cancer Institute. Parents will also be provided with relevant educational brochures from COG. Each session will also include a structured set of questions that will facilitate discussion. All ESO interventionists will be trained in non-directive approaches including reflective listening. Content provided in the ESO sessions will offer valuable information to parents without providing the specific skills of the IMPACT.
Intervention Type
Behavioral
Intervention Name(s)
IMPACT
Other Intervention Name(s)
Parent Uncertainty Management Intervention
Intervention Description
• The intervention is 6 sessions lasting approximately 45 minutes reviewing ways to help prevent and respond to illness uncertainty. Sessions occur weekly at already scheduled clinic appointments. Interventions will be delivered by a trained interventionist.
Intervention Type
Other
Intervention Name(s)
ESO
Other Intervention Name(s)
Education/Support Only
Intervention Description
This control is 6 sessions lasting approximately 45 minutes providing education on cancer etiology, medical treatments, side effects, potential short- and long-term effects of treatment and resources that are often helpful to parents of children with cancer. Sessions occur weekly at already scheduled clinic appointments. Interventions will be delivered by a trained interventionist.
Primary Outcome Measure Information:
Title
Psychosocial Functioning as assessed by the global severity index (GSI) of the symptom checklist 90.
Description
indicator of global psychological symptoms
Time Frame
Change in (global severity index) GSI score from baseline to 1-week post-intervention
Title
Psychosocial Functioning as assessed by the global severity index of the symptom checklist 90.
Description
indicator of global psychological symptoms
Time Frame
Change in GSI score from baseline to 3-month post-intervention
Title
Psychosocial Functioning as assessed by the global severity index of the symptom checklist 90.
Description
indicator of global psychological symptoms
Time Frame
Change in GSI score from baseline to 6-month post-intervention
Title
Psychosocial Functioning as assessed by the global severity index of the symptom checklist 90.
Description
indicator of global psychological symptoms
Time Frame
Change in GSI score from baseline to 12-month post-intervention
Secondary Outcome Measure Information:
Title
Post-Traumatic Stress Symptoms as assessed by the Impact of Events Scale-Revised (IES-R)
Description
Measure of caregiver post-traumatic stress symptoms
Time Frame
Change in IES-R total score score from baseline to 1-week post-intervention
Title
Post-Traumatic Stress Symptoms as assessed by the Impact of Events Scale-Revised (IES-R)
Description
Measure of caregiver post-traumatic stress symptoms
Time Frame
Change in IES-R total score score from baseline to 3-month post-intervention
Title
Post-Traumatic Stress Symptoms as assessed by the Impact of Events Scale-Revised (IES-R)
Description
Measure of caregiver post-traumatic stress symptoms
Time Frame
Change in IES-R total score score from baseline to 6-month post-intervention
Title
Post-Traumatic Stress Symptoms as assessed by the Impact of Events Scale-Revised (IES-R)
Description
Measure of caregiver post-traumatic stress symptoms
Time Frame
Change in IES-R total score score from baseline to 12-month post-intervention

10. Eligibility

Sex
All
Minimum Age & Unit of Time
0 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: The child has been diagnosed with leukemia or lymphoma, malignant solid tumor, or malignant brain tumor The child is being treated for cancer and returning to the medical center (CCHMC or OUHSC). The child is 18 years of age or younger Recruitment occurs within 2-12 weeks post diagnosis The parent is responsible for care and is willing to give consent and participate The child is willing to give assent or consent and participate (only for children 8 years old and older) The parent gives patient permission to participate. Parent is fluent in English Exclusion Criteria: The child is experiencing an imminent medical crisis necessitating significant medical intervention The child with cancer is determined to be in the terminal phase of illness and/or is receiving end of life care The diagnosis is determined to be a relapse or a second malignancy The parent is currently being treated for a serious psychiatric disorder, or, evidences mental retardation The parent is younger than 18 years of age The parent is not English speaking The parent is unwilling to give written permission for child participation If the patient's treatment visit schedule is too infrequent to meet the study visit timeline requirements
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ahna LH Pai, PhD
Organizational Affiliation
Children's Hospital Medical Center, Cincinnati
Official's Role
Principal Investigator
Facility Information:
Facility Name
Cincinnati Children's Hospital Medical Center
City
Cincinnati
State/Province
Ohio
ZIP/Postal Code
45229
Country
United States
Facility Name
Dayton Children's Hospital
City
Dayton
State/Province
Ohio
ZIP/Postal Code
45404
Country
United States
Facility Name
University of Oklahoma Health Sciences Center
City
Oklahoma City
State/Province
Oklahoma
ZIP/Postal Code
73104
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Undecided
IPD Sharing Plan Description
Due to the sensitive nature of the measures that provided information on the participants psychologically symptoms the final dataset will be stripped of identifiers prior to any release for sharing, we believe that there remains the possibility of deductive disclosure of subjects with unusual characteristics due the relatively rare pediatric oncological diagnoses of the children in the study. Thus, we will make the data and associated documentation available to users only under a data-sharing agreement that provides for: (1) a commitment to using the data only for research purposes and not to identify any individual participant; (2) a commitment to securing the data using the highest standards of practice; and (3) a commitment to destroying or returning the data after analyses are completed.
Citations:
PubMed Identifier
28177514
Citation
Szulczewski L, Mullins LL, Bidwell SL, Eddington AR, Pai ALH. Meta-Analysis: Caregiver and Youth Uncertainty in Pediatric Chronic Illness. J Pediatr Psychol. 2017 May 1;42(4):395-421. doi: 10.1093/jpepsy/jsw097.
Results Reference
background
PubMed Identifier
32196095
Citation
Sharkey CM, Schepers SA, Drake S, Pai ALH, Mullins LL, Grootenhuis MA. Psychosocial Risk Profiles Among American and Dutch Families Affected by Pediatric Cancer. J Pediatr Psychol. 2020 May 1;45(4):463-473. doi: 10.1093/jpepsy/jsaa012.
Results Reference
background
PubMed Identifier
26836990
Citation
Morrison CF, Szulczewski L, Strahlendorf LF, Lane JB, Mullins LL, Pai AL. Designing Technology to Address Parent Uncertainty in Childhood Cancer. ANS Adv Nurs Sci. 2016 Jan-Mar;39(1):15-25. doi: 10.1097/ANS.0000000000000100.
Results Reference
result
PubMed Identifier
28652227
Citation
Marsolo K, Shuman W, Nix J, Morrison CF, Mullins LL, Pai AL. Reducing Parental Uncertainty Around Childhood Cancer: Implementation Decisions and Design Trade-Offs in Developing an Electronic Health Record-Linked Mobile App. JMIR Res Protoc. 2017 Jun 26;6(6):e122. doi: 10.2196/resprot.7523.
Results Reference
result
PubMed Identifier
34350968
Citation
Basile NL, Chardon ML, Peugh J, Edwards CS, Szulczewski L, Morrison CF, Nagarajan R, El-Sheikh A, Chaney JM, Pai ALH, Mullins LL. Relationship Between Caregiver Uncertainty, Problem-Solving, and Psychological Adjustment in Pediatric Cancer. J Pediatr Psychol. 2021 Oct 18;46(10):1258-1266. doi: 10.1093/jpepsy/jsab065.
Results Reference
result
PubMed Identifier
28659258
Citation
Nebeker C, Murray K, Holub C, Haughton J, Arredondo EM. Acceptance of Mobile Health in Communities Underrepresented in Biomedical Research: Barriers and Ethical Considerations for Scientists. JMIR Mhealth Uhealth. 2017 Jun 28;5(6):e87. doi: 10.2196/mhealth.6494.
Results Reference
derived

Learn more about this trial

Illness Management and Parental Adjustment to Cancer Treatment

We'll reach out to this number within 24 hrs